Showing results (61-70 of 63) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Gastroenterology Report|August 19, 2022
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease modelSang Hyun Seo, Da Hyun Lee, Yu Seol Lee, et al.Hepatology (Baltimore, Md.)|November 13, 2021
A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiomeEun Ran Kim, Jeong Su Park, Jin Hee Kim, et al.Free Radical Biology & Medicine|September 17, 2016
Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitisDa Hyun Lee, Dai Hoon Han, Ki Taek Nam, et al.Pageof 7